Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07366970

Is There a Benefit From Addition of Exercise in Diabetic Patients With ED Who Complain Low Vitamin D?

males with diabetes complain impotence in the presence of low vitamin D deficiency. pharacmological treatment of low vitamin D levels is necessary but changing lifestyle by performing exercise is also important

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Diabetes Mellitus Avitaminosis Deficiency Diseases Endocrine System Diseases Erectile Dysfunction Genital Diseases Genital Diseases, Male Glucose Metabolism Disorders Male Urogenital Diseases Malnutrition Mental Disorders Metabolic Diseases Nutrition Disorders Nutritional and Metabolic Diseases Sexual Dysfunction, Physiological Sexual Dysfunctions, Psychological Urogenital Diseases Vitamin D Deficiency

Age range

35 year–45 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Cairo University

Dokki, Giza Governorate, 11432, Egypt

Location status: Recruiting

Location contact

ali AM Ismail, lecturer

CONTACT

[email protected]

+201005154209

About this study

forty diabetic men (type 2) who complain presence of low vitamin D and impotence will be divided to group number I and group number II. Both groups will be pharmacologically treated by administration of Cholecalciferol 200.000 I.U (will be taken every two weeks). this treatment will last for 12 weeks. Additionally, Group number I will perform treadmill walking (one hour walking) with moderate intensity. This walking will be performed three times per designed week for twelve weeks.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • diabetic men (forty)
  • type 2 diabetes
  • complaint of erectile dysfucntion (chronic complaint more than 24 months)
  • men with low vitamin D (deiciency in vitamin D)

Exclusion criteria

  • cardiac patients
  • respiratory disease patients
  • renal disease
  • liver disease

Treatment and study plan

exercise and vitamin D intake

Behavioral

twenty diabetic men (type 2) who complain presence of low vitamin D and impotence will be pharmacologically treated by administration of Cholecalciferol 200.000 I.U (will be taken every two weeks). this treatment will last for 12 weeks. Additionally, Group number I will perform treadmill walking (one hour walking) with moderate intensity. This walking will be performed three times per designed week for twelve weeks.

vitamin D intake

Other

twenty diabetic men (type 2) who complain presence of low vitamin D and impotence will be pharmacologically treated by administration of Cholecalciferol 200.000 I.U (will be taken every two weeks). this treatment will last for 12 weeks.

Primary outcomes

  1. international index of erectile function

    Time frame: it will be measured after 12 weeks

    questionnaire used to assess impotence

Secondary outcomes

  1. glycated hemoglubin

    Time frame: It will be measured after 12 weeks

    it will be used to assess blood glcuose

  2. fasting blood glcuose

    Time frame: It will be measured after 12 weeks

    it will be used to assess blood glcuose in serum

  3. body mass index

    Time frame: It will be measured after 12 weeks

    it will be measured on empty stomach and bladder

  4. wasit circumference

    Time frame: it will be measured after 12 weeks

    it will be measured at umbilicus level

  5. high density lipoprotein

    Time frame: It will be measured after 12 weeks

    it will be measured in serum

  6. low density lipoprotein

    Time frame: It will be measured after 12 weeks

    it will be measured in serum

  7. triglycerides

    Time frame: It will be measured after 12 weeks

    it will be assessed in serum

  8. cholesterol

    Time frame: It will be measured after 12 weeks

    it will be assessed in serum

  9. 25-hydroxyvitamin D

    Time frame: It will be measured after 12 weeks

    it will be assessed in serum as a metabolite of vitamin D

Study contacts

Contact information is provided by the study sponsor or research team.

Ali MA Ismail, lecturer

CONTACT

[email protected]

01005154209

Ali mohamed, lecturer

CONTACT

[email protected]

01031321109

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Registry information

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Jan 26, 2026
Registry last updated
Jan 26, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.